Global Biobanking Market

Global Biobanking Market Research Report 2021

Global Biobanking Market

Global Biobanking Market Research Report 2021

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Biobanking Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Biobanking Market Overview:

Global Biobanking Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Biobanking involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Biobanking Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Biobanking market in 2020.

Global Biobanking Market Segmentation

By Type, Biobanking market has been segmented into:

Equipment

Consumable

By Application, Biobanking market has been segmented into:

Virtual Biobanks

Tissue Biobanks

Population Biobanks

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Biobanking market are:

Beckman Coulter

Thermo Fisher

Panasonic

Sigma-Aldrich

SOL Group

Promega

BD

Brooks Life Science

QIAGEN

Tecan Group

Lifeline Scientific

So-Low

LVL Technologies

DNA Genotek

Micronic

Askion

Biolife Solutions

Cryo Bio System

BioRep

1. Market Overview of Biobanking

1.1 Biobanking Market Overview

1.1.1 Biobanking Product Scope

1.1.2 Market Status and Outlook

1.2 Biobanking Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Biobanking Historic Market Size by Regions (2015-2020)

1.4 Biobanking Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Biobanking Sales Market by Type (2015-2026)

2.1 Global Biobanking Historic Market Size by Type (2015-2020)

2.2 Global Biobanking Forecasted Market Size by Type (2021-2026)

2.3 Equipment

2.4 Consumable

3. Covid-19 Impact Biobanking Sales Market by Application (2015-2026)

3.1 Global Biobanking Historic Market Size by Application (2015-2020)

3.2 Global Biobanking Forecasted Market Size by Application (2021-2026)

3.3 Virtual Biobanks

3.4 Tissue Biobanks

3.5 Population Biobanks

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Biobanking Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Biobanking Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Biobanking Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Biobanking Business

5.1 Beckman Coulter

5.1.1 Beckman Coulter Company Profile

5.1.2 Beckman Coulter Biobanking Product Specification

5.1.3 Beckman Coulter Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Thermo Fisher

5.2.1 Thermo Fisher Company Profile

5.2.2 Thermo Fisher Biobanking Product Specification

5.2.3 Thermo Fisher Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 Panasonic

5.3.1 Panasonic Company Profile

5.3.2 Panasonic Biobanking Product Specification

5.3.3 Panasonic Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Sigma-Aldrich

5.4.1 Sigma-Aldrich Company Profile

5.4.2 Sigma-Aldrich Biobanking Product Specification

5.4.3 Sigma-Aldrich Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 SOL Group

5.5.1 SOL Group Company Profile

5.5.2 SOL Group Biobanking Product Specification

5.5.3 SOL Group Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Promega

5.6.1 Promega Company Profile

5.6.2 Promega Biobanking Product Specification

5.6.3 Promega Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 BD

5.7.1 BD Company Profile

5.7.2 BD Biobanking Product Specification

5.7.3 BD Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 Brooks Life Science

5.8.1 Brooks Life Science Company Profile

5.8.2 Brooks Life Science Biobanking Product Specification

5.8.3 Brooks Life Science Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 QIAGEN

5.9.1 QIAGEN Company Profile

5.9.2 QIAGEN Biobanking Product Specification

5.9.3 QIAGEN Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 Tecan Group

5.10.1 Tecan Group Company Profile

5.10.2 Tecan Group Biobanking Product Specification

5.10.3 Tecan Group Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 Lifeline Scientific

5.11.1 Lifeline Scientific Company Profile

5.11.2 Lifeline Scientific Biobanking Product Specification

5.11.3 Lifeline Scientific Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 So-Low

5.12.1 So-Low Company Profile

5.12.2 So-Low Biobanking Product Specification

5.12.3 So-Low Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 LVL Technologies

5.13.1 LVL Technologies Company Profile

5.13.2 LVL Technologies Biobanking Product Specification

5.13.3 LVL Technologies Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.14 DNA Genotek

5.14.1 DNA Genotek Company Profile

5.14.2 DNA Genotek Biobanking Product Specification

5.14.3 DNA Genotek Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.15 Micronic

5.15.1 Micronic Company Profile

5.15.2 Micronic Biobanking Product Specification

5.15.3 Micronic Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.16 Askion

5.16.1 Askion Company Profile

5.16.2 Askion Biobanking Product Specification

5.16.3 Askion Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.17 Biolife Solutions

5.17.1 Biolife Solutions Company Profile

5.17.2 Biolife Solutions Biobanking Product Specification

5.17.3 Biolife Solutions Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.18 Cryo Bio System

5.18.1 Cryo Bio System Company Profile

5.18.2 Cryo Bio System Biobanking Product Specification

5.18.3 Cryo Bio System Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.19 BioRep

5.19.1 BioRep Company Profile

5.19.2 BioRep Biobanking Product Specification

5.19.3 BioRep Biobanking Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Biobanking Market Size (2015-2026)

6.2 North America Biobanking Key Players in North America (2015-2020)

6.3 North America Biobanking Market Size by Type (2015-2020)

6.4 North America Biobanking Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Biobanking Market Size (2015-2026)

7.2 East Asia Biobanking Key Players in North America (2015-2020)

7.3 East Asia Biobanking Market Size by Type (2015-2020)

7.4 East Asia Biobanking Market Size by Application (2015-2020)

8. Europe

8.1 Europe Biobanking Market Size (2015-2026)

8.2 Europe Biobanking Key Players in North America (2015-2020)

8.3 Europe Biobanking Market Size by Type (2015-2020)

8.4 Europe Biobanking Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Biobanking Market Size (2015-2026)

9.2 South Asia Biobanking Key Players in North America (2015-2020)

9.3 South Asia Biobanking Market Size by Type (2015-2020)

9.4 South Asia Biobanking Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Biobanking Market Size (2015-2026)

10.2 Southeast Asia Biobanking Key Players in North America (2015-2020)

10.3 Southeast Asia Biobanking Market Size by Type (2015-2020)

10.4 Southeast Asia Biobanking Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Biobanking Market Size (2015-2026)

11.2 Middle East Biobanking Key Players in North America (2015-2020)

11.3 Middle East Biobanking Market Size by Type (2015-2020)

11.4 Middle East Biobanking Market Size by Application (2015-2020)

12. Africa

12.1 Africa Biobanking Market Size (2015-2026)

12.2 Africa Biobanking Key Players in North America (2015-2020)

12.3 Africa Biobanking Market Size by Type (2015-2020)

12.4 Africa Biobanking Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Biobanking Market Size (2015-2026)

13.2 Oceania Biobanking Key Players in North America (2015-2020)

13.3 Oceania Biobanking Market Size by Type (2015-2020)

13.4 Oceania Biobanking Market Size by Application (2015-2020)

14. South America

14.1 South America Biobanking Market Size (2015-2026)

14.2 South America Biobanking Key Players in North America (2015-2020)

14.3 South America Biobanking Market Size by Type (2015-2020)

14.4 South America Biobanking Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Biobanking Market Size (2015-2026)

15.2 Rest of the World Biobanking Key Players in North America (2015-2020)

15.3 Rest of the World Biobanking Market Size by Type (2015-2020)

15.4 Rest of the World Biobanking Market Size by Application (2015-2020)

16 Biobanking Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Biobanking Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Biobanking Market?
Some of the finest and top-notch companies pioneering the Biobanking Market are Beckman Coulter, Thermo Fisher, Panasonic, Sigma-Aldrich, SOL Group, Promega, BD, Brooks Life Science, QIAGEN, Tecan Group, Lifeline Scientific, So-Low, LVL Technologies, DNA Genotek, Micronic, Askion, Biolife Solutions, Cryo Bio System, BioRep.
What trends are influencing the growth of the Biobanking Market?
New players are entering the Biobanking Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
What important business segments are segregated by application types in the latest edition of the Biobanking Market?
The key business segments in the Biobanking Market are segregated by applications [Virtual Biobanks, Tissue Biobanks, Population Biobanks] and types [Equipment, Consumable].
What is the size of the Biobanking Industry?
According to the report, the Biobanking Industry will grow to USD XXX Million by 2030, with a YY% CAGR.
What challenges does the Biobanking Market face in the future?
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Biobanking Market across the extensive corporate landscape.
What does the future hold for the Biobanking Industry?
This latest research publication on the Biobanking Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.